Investor relations pageIR page | no data available |
Founding year | no data available |
Headquarter | , , no data available |
Employees | 445 (as per Q2 2016)no data available |
Sector | Medical Diagnostics & Research, HealthcareMedical Diagnostics & Research, Healthcareno data available |
Ticker | OXFDno data available |
Financial year endsFY ends | End of Decemberno data available |
Last Closing Price as per Oct 13, 2017, in USD |
16.85n/a |
Market Capitalisation in million USD |
380n/a |
Enterprise Value in million USD |
440n/a |
Common Shares Outstanding as per Jul 27, 2016 |
22,569,881n/a |
Preferred Shares Outstanding as per Jul 27, 2016 |
7,301,321n/a |
Average Basic Shares Outstanding TTM |
21,781,933n/a |
Average Diluted Shares Outstanding TTM |
22,296,669n/a |
Index Membership |
, US 3000
n/a
|
Revenues | 71n/a |
Gross Profit | 38n/a |
Operating Income | -26n/a |
EBITDA | -23n/a |
Net Profit | -24n/a |
Cash and Cash Equivalents | 64n/a |
Receivables | 10n/a |
Total Current Assets | 85n/a |
PP&E | 7n/a |
Total Assets | 94n/a |
Accounts Payable | 3n/a |
Current Debt | 0n/a |
Total Current Liabilities | 11n/a |
Long-Term Debt | 0n/a |
Total Liabilities | 13n/a |
Total Equity | 80n/a |
Depreciation & Amortisation | 2n/a |
Change in Working Capital | -5n/a |
Operating Cash Flow | -22n/a |
Net Change in PP&E and Intangibles | -3n/a |
Investing Cash Flow | -3n/a |
Dividends Paid | 0n/a |
Financing Cash Flow | 0n/a |
Total Change in Cash | -26n/a |
Free Cash Flow | -32n/a |
Gross Margin | 53.3%n/a |
Operating Margin | -36.0%n/a |
Net Profit Margin | -34.3%n/a |
Return on Equity | -30.3%n/a |
Return on Assets | -26.0%n/a |
Basic EPS | n/a |
Diluted EPS | -1.09n/a |
Sales per Share | n/a |
Book Value per Share | n/a |
FCF per Share | n/a |
Dividends per Share | n/a |
Price to Earnings Ratio | n/a |
Price to Sales Ratio | n/a |
Price to Book Value | n/a |
Price to Free Cash Flow | n/a |
EV/EBITDA | -18.98n/a |
EV/Sales | 6.19n/a |
Book to Market Value | 0.21n/a |
Current Ratio | 739.7%n/a |
Liabilities to Equity Ratio | 16.5%n/a |
Debt to Assets Ratio | 0.4%n/a |
in million USD | FY '12 | FY '13 | FY '14 | FY '15 |
---|---|---|---|---|
|
21
|
39
|
50
|
63
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
-12
|
-19
|
-24
|
-30
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
8
|
20
|
25
|
33
|
|
0
|
0
|
0
|
0
|
|
-21
|
-28
|
-47
|
-57
|
|
-19
|
-25
|
-40
|
-46
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
-2
|
-2
|
-7
|
-11
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
-13
|
-7
|
-22
|
-24
|
|
-2
|
-1
|
0
|
0
|
|
-1
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
-1
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
-15
|
-9
|
-22
|
-24
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
-15
|
-9
|
-22
|
-24
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
-15
|
-9
|
-22
|
-24
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
-15
|
-9
|
-22
|
-24
|
|
0
|
0
|
0
|
0
|
|
-15
|
-9
|
-22
|
-24
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
-15
|
-9
|
-22
|
-24
|
Remarks |
restated on Mar 5, 2015
n/a
calculated values,
|
restated on Mar 1, 2016
n/a
calculated values,
|
restated on Mar 1, 2016
n/a
calculated values,
|
restated on Mar 1, 2016
n/a
calculated values,
|
in million USD | FY '12 | FY '13 | FY '14 | FY '15 |
---|---|---|---|---|
Assets | ||||
|
n/a
|
76
|
50
|
84
|
|
n/a
|
76
|
50
|
84
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
5
|
7
|
7
|
|
n/a
|
5
|
7
|
7
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
5
|
6
|
7
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
2
|
3
|
4
|
|
n/a
|
2
|
3
|
4
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
89
|
66
|
101
|
|
n/a
|
3
|
5
|
6
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
1
|
3
|
2
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
0
|
0
|
|
n/a
|
0
|
3
|
2
|
|
n/a
|
4
|
7
|
8
|
|
n/a
|
93
|
74
|
110
|
Liabilities and owners' equity | ||||
|
n/a
|
9
9423000
|
9
9438000
|
14
13748000
|
|
n/a
|
2
2310000
|
2
2368000
|
4
3799000
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
7
7113000
|
7
7070000
|
10
9949000
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
2
1710000
|
2
2130000
|
2
1733000
|
|
n/a
|
2
1540000
|
2
1993000
|
2
1654000
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
0
170000
|
0
137000
|
0
79000
|
|
n/a
|
11
11133000
|
12
11568000
|
15
15481000
|
|
n/a
|
1
563000
|
0
454000
|
0
386000
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
0
296000
|
1
1218000
|
1
1293000
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
0
296000
|
1
1218000
|
1
1293000
|
|
n/a
|
1
859000
|
2
1672000
|
2
1679000
|
|
n/a
|
12
11992000
|
13
13240000
|
17
17160000
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
184
184155000
|
187
187008000
|
244
244276000
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
-100
-99655000
|
-122
-121829000
|
-146
-146307000
|
|
n/a
|
-4
-3748000
|
-5
-4570000
|
-5
-5277000
|
|
n/a
|
81
80752000
|
61
60609000
|
93
92692000
|
|
n/a
|
0
0
|
0
0
|
0
0
|
|
n/a
|
81
80752000
|
61
60609000
|
93
92692000
|
|
n/a
|
93
92744000
|
74
73849000
|
110
109852000
|
Remarks | restated on n/a | restated on Mar 5, 2015 n/a | restated on Mar 1, 2016 n/a | restated on Aug 2, 2016 n/a |
in million USD | FY '12 | FY '13 | FY '14 | FY '15 |
---|---|---|---|---|
|
-15
|
-9
|
-22
|
-24
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
1
|
1
|
2
|
2
|
|
2
|
1
|
3
|
4
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
-2
|
1
|
-3
|
2
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
-14
|
-6
|
-21
|
-17
|
|
-2
|
-2
|
-3
|
-3
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
-2
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
-2
|
-2
|
-5
|
-3
|
|
0
|
0
|
0
|
0
|
|
14
|
4
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
13
|
67
|
0
|
54
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
|
26
|
71
|
0
|
54
|
|
10
|
63
|
-26
|
34
|
|
0
|
0
|
0
|
0
|
|
10
|
63
|
-26
|
34
|
|
0
|
1
|
0
|
0
|
|
10
|
64
|
-26
|
34
|
Remarks |
restated on Mar 5, 2015
n/a
calculated values,
|
restated on Mar 1, 2016
n/a
calculated values,
|
restated on Mar 1, 2016
n/a
calculated values,
|
restated on Mar 1, 2016
n/a
calculated values,
|